Interferon gamma anticorps (HRP)

N° du produit ABIN6963841

Cet anticorps anti-Interferon gamma est un anticorps Souris Monoclonal détectant Interferon gamma dans ELISA et ELISpot. Adapté pour Humain et Non-Human Primate. Ce Primary Antibody a été cité dans 5+ publications.

Aperçu rapide pour Interferon gamma anticorps (HRP) (ABIN6963841)

Antigène: Interferon gamma (IFNG)

Reactivité: Humain, Non-Human Primate

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Interferon gamma est conjugé à/à la HRP

Application: ELISA, ELISpot

Clone: 7-B6-1

Détail du produit anti-Interferon gamma anticorps (HRP)

Specificité: Native and recombinant IFN-γ

Réactivité croisée (Details): The monoclonal antibody cross-reacts with IFN-γ from non-human primates.

Purification: Purified from in vitro cultures by protein G affinity chromatography.

Immunogène: Recombinant human IFN-gamma

Isotype: IgG1

Information d'application

Indications d'application: For quantification of IFN-γ in solution e.g. cell culture supernatants using ELISA and for enumeration of IFN-γ producing cells using ELISpot. 7-B6-1 is recommended as detection mAb in combination with coating mAb 1-D1K for human IFN-γ .

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: supplied storage buffer with 0.002 % Kathon CG

Stock: 4 °C

Stockage commentaire: Store product at 4-8°C.

Date de péremption: 18 months

Références pour anticorps anti-Interferon gamma (HRP) (ABIN6963841)

Sauermann, Radaelli, Stolte-Leeb, Raue, Bissa, Zanotto, Krawczak, Tenbusch, Überla, Keele, De Giuli Morghen, Sopper, Stahl-Hennig: "Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses." dans: Journal of virology, Vol. 91, Issue 23, (2019) (PubMed).

Cirac, Stützle, Dieckmeyer, Adhikary, Moosmann, Körber, Bauer, Witter, Delecluse, Behrends, Mautner: "Epstein-Barr virus strain heterogeneity impairs human T-cell immunity." dans: Cancer immunology, immunotherapy : CII, Vol. 67, Issue 4, pp. 663-674, (2019) (PubMed).

Callendret, Vellinga, Wunderlich, Rodriguez, Steigerwald, Dirmeier, Cheminay, Volkmann, Brasel, Carrion, Giavedoni, Patterson, Mire, Geisbert, Hooper, Weijtens, Hartkoorn-Pasma, Custers, Grazia Pau et al.: "A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. ..." dans: PLoS ONE, Vol. 13, Issue 2, pp. e0192312, (2018) (PubMed).

Gubin, Zhang, Schuster, Caron, Ward, Noguchi, Ivanova, Hundal, Arthur, Krebber, Mulder, Toebes, Vesely, Lam, Korman, Allison, Freeman, Sharpe, Pearce, Schumacher, Aebersold, Rammensee, Melief, Mardis et al.: "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. ..." dans: Nature, Vol. 515, Issue 7528, pp. 577-81, (2015) (PubMed).

Czerkinsky, Andersson, Ekre, Nilsson, Klareskog, Ouchterlony: "Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells." dans: Journal of immunological methods, Vol. 110, Issue 1, pp. 29-36, (1988) (PubMed).

Détails sur Interferon gamma

Antigène: Interferon gamma (IFNG)

Autre désignation: IFNG

ID gène: 3458

Pathways: Interferon-gamma Pathway, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy